Kevin Moran
Chief Financial Officer
Replay available
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Chief Financial Officer
President, Chief Executive Officer and Chairman of the Board
Analyst, H.E. Wainwright
Analyst, Cantor
Analyst, Jefferies (on behalf of Andrew Chai)
Watch the replay and follow the connected company analysis, news, and investor updates for Vanda Pharmaceuticals Inc..
WEBVTT 00:00:00.098 -- 00:00:03.901 Hello and thank you for standing by. My name is Mark and I will be your conference operator 00:00:03.901 -- 00:00:09.386 today. At this time, I would like to welcome everyone to the Q3 2025 Vanta Pharmaceuticals 00:00:09.386 -- 00:00:13.670 Inc. earnings conference call. All lines have been placed on mute to prevent any background 00:00:13.670 -- 00:00:18.555 noise. After the speaker's remarks, there will be a question and answer session. 00:00:18.555 -- 00:00:21.637 If you would like to ask a question during this time, simply press star followed by the 00:00:21.637 -- 00:00:26.282 number one on your telephone keypad. And to withdraw your question, press star one again. 00:00:26.282 -- 00:00:29.242 Now I would like to turn the call over to Kevin Moran. 00:00:29.242 -- 00:00:33.264 Vandas Chief Financial Officer, please go ahead. 00:00:33.547 -- 00:00:38.493 Thank you, Mark. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceutical's 00:00:38.493 -- 00:00:43.499 third quarter 2025 performance. Our third quarter 2025 results 00:00:43.499 -- 00:00:47.564 were released this afternoon and are available on the SEC's editor system and on our 00:00:47.564 -- 00:00:50.585 website, www.vandapharma.com. 00:00:51.749 -- 00:00:55.754 In addition, we are providing live and archived versions of this conference call on our 00:00:55.754 -- 00:00:57.355 website. 00:00:57.355 -- 00:01:01.821 Joining me on today's call is Dr. Mahalis Polymeropoulos, our President, Chief Executive 00:01:01.821 -- 00:01:06.727 Officer, and Chairman of the Board, and Tim Williams, our General Counsel. 00:01:06.727 -- 00:01:11.112 Following my introductory remarks, Mahalis will update you on our ongoing activities. 00:01:11.112 -- 00:01:15.838 I will th...